Pfizer invites interdisciplinary independent medical education proposals aimed at strengthening the competency of healthcare professionals involved in the management of adults with ulcerative colitis who are initiating S1Prm therapy.
Donor Name: Pfizer
State: All States
County: All Counties
Type of Grant: Grant
Deadline: 04/14/2026
Size of the Grant: $500,000 to $1 million
Grant Duration: Less than 1 Year
Details:
A significant knowledge gap persists among healthcare professionals regarding the baseline evaluations required when initiating sphingosine 1-phosphate receptor modulator (S1Prm) therapy for the treatment of moderately to severely active ulcerative colitis in adults. Education is needed on the role of electrocardiogram (ECG) and conduction assessment for appropriate patient identification prior to initiation. In addition, education is needed on performing an ECG, eye exam, and skin exam prior to starting S1Prm therapy in adults with ulcerative colitis.
Project Types and Area of Interest
Educational projects eligible for Pfizer support should integrate expertise from specialists (e.g., gastroenterology, cardiology, electrophysiology, S1Prm pharmacology, dermatology, ophthalmology, etc) to deliver comprehensive education on baseline assessments, especially ECG, outlined in the current U.S. Prescribing Information for S1Prm therapy.
Funding Information
- The estimated total available budget related to this RFP is $100,000.00 USD. Individual projects requesting up to $100,000USD will be considered.
- Maximum project length is 6 months.
Geographic Scope
United States
Eligibility Criteria
The following may apply: medical doctor, nurse, healthcare institutions, professional organizations/medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement.
- Only organizations are eligible to receive grants, not individuals or medical practice groups (i.e., an independent group of physicians not affiliated with a hospital, academic institution, or professional society)
- If the project involves multiple departments within an institution and/or between different institutions / organizations / associations, all institutions must have a relevant role and the requesting organization must have a key role in the project
- The applicant must be the project/program lead or an authorized designee of such individual (e.g., project/program lead’s grant coordinator).
- The project/program lead must be an employee or contractor of the requesting organization.
- Requesting organization must be legally able to receive award funding directly from Pfizer Inc. They strongly recommend that applicants confirm this with their organization or institution prior to submitting an application. Grants awarded to organizations that are subsequently found to be unable to accept funding directly from Pfizer Inc. may be subject to rescission.
- For projects offering continuing education credit, the requesting organization must be accredited.
Requirements
Primary Area of Interest:
- Gastroenterology – Ulcerative Colitis.
Specific Area of Interest for this RFP: Educational projects eligible for Pfizer support should address the following components:
- Educational Leads: Programs should be led by interdisciplinary key opinion leaders with expertise in relevant assessments (e.g., gastroenterology, cardiology, electrophysiology, dermatology, ophthalmology, and S1Prm pharmacology).
- Format: Priority will be given to face-to-face discussions that facilitate active engagement between faculty and participants, including but not limited to case-based demonstrations of pre-treatment evaluations. Additional educational formats—such as seminars, symposia, and live webinars—may also be considered.
- Educational Content: Projects should provide thorough coverage of the required assessments, such as cardiological aspects outlined in the current U.S. prescribing information for S1Prm therapy. This may include interpretation of cardiology surveillance data, detailed discussion of ECG requirements (e.g., type of ECG, timing flexibility prior to treatment initiation) and recommended best clinical practices.
- Educational Outcomes: Applicants are encouraged to define clear educational metrics, such as estimated learner reach, demonstrated increases in knowledge through pre- and post-activity assessments, and the projected number of patients potentially affected by improved clinical practices. Publication of data driven commentary or perspective article authored by the educational leads is strongly encouraged to disseminate insights and further advance discourse in the field.
- Target Audience:
- Gastroenterologists, nurses, pharmacists, advanced practice providers, and primary care providers, involved in S1Prm therapy initiation workflows.
For more information, visit Pfizer.
